How should a shingles (herpes zoster) infection be treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Treatment of Shingles (Herpes Zoster) Infection

Start oral antiviral therapy with valacyclovir or famciclovir within 72 hours of rash onset to reduce disease severity, duration, and risk of postherpetic neuralgia. 1, 2, 3

Antiviral Treatment

The cornerstone of shingles management is prompt antiviral therapy. You should prescribe one of three first-line antivirals:

  • Valacyclovir (preferred)
  • Famciclovir (preferred)
  • Acyclovir (acceptable but requires more frequent dosing)

2, 3

The 72-hour window is critical—antivirals work by inhibiting viral replication, so earlier initiation yields better outcomes in terms of rash healing, acute pain reduction, and prevention of postherpetic neuralgia (PHN). 1, 2 However, do not withhold antivirals if a patient presents after 72 hours, especially if new vesicles are still forming, the patient is immunocompromised, or there is involvement of high-risk areas (ophthalmic, disseminated disease). 1

Special Populations Requiring Aggressive Treatment

Immunocompromised patients warrant particular attention. In HIV-infected individuals, herpes zoster occurs 15-fold more frequently than in age-matched controls, with highest rates when CD4+ counts fall below 200 cells/µL. 4 These patients face 25-50% risk of cutaneous dissemination and 10-30% recurrence rates within the first year. 4

For immunocompromised patients with severe disease or visceral dissemination (especially VZV pneumonitis), consider:

  • Intravenous acyclovir for initial management
  • Ganciclovir or foscarnet if standard antivirals fail (using CMV disease dosing schedules) 4

Pain Management

Acute zoster pain can be severe and debilitating. Address pain control simultaneously with antiviral therapy:

  • Acute pain: Analgesics ranging from acetaminophen/NSAIDs to opioids depending on severity 1
  • Neuropathic pain: Consider early initiation of gabapentin or pregabalin 2
  • Topical therapy: Lidocaine patches for localized pain relief 2

The goal is dual: control current suffering and prevent progression to PHN, which affects 10-20% of patients and is defined as pain persisting beyond 90 days. 4, 2

Local Skin Care

Maintain good wound hygiene to promote healing and prevent secondary bacterial infection. 3 Keep lesions clean and dry. Crusts typically persist for 2-3 weeks before resolving. 4

Critical Pitfalls to Avoid

  1. Do not delay treatment waiting for laboratory confirmation—diagnosis is clinical based on the characteristic dermatomal painful vesicular rash 5, 1

  2. Do not miss ophthalmic zoster—involvement of cranial nerves (20-25% of cases) requires urgent ophthalmology consultation to prevent vision loss 4, 6

  3. Do not assume one episode provides immunity—20-30% of HIV-infected patients experience recurrent episodes, with ~10% recurring within one year 4

  4. Do not overlook dissemination risk—most complications occur with CD4+ counts <200 cells/µL, including CNS involvement 4

Treatment Efficacy

Both valacyclovir and famciclovir are the only interventions proven to prevent PHN when started early. 3 This makes the 72-hour window even more critical for long-term outcomes, as PHN can be severely debilitating and difficult to treat once established. 6, 2

The European consensus guideline emphasizes that treatment aims to improve acute disease duration, reduce acute pain, enhance quality of life, and most importantly, reduce PHN incidence. 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.